Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Summit Therapeutics Inc (SMMT)

225 + Investors. Track Smart Money conviction in SMMT. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +13
Streak
1Q ▲
Buyers last Q
60%

Smart Money Signals — SMMT

Based on 225 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds added SMMT than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
📊

High ownership — 93% of 3.0Y peak

93% of all-time peak
225 funds currently hold this stock — 93% of the 3.0-year high of 241 funds (reached 2025 Q2). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.
📶

Steady growth — +5% more funds vs a year ago

fund count last 6Q
+10 new funds entered over the past year (+5% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.
🟢

More buyers than sellers — 60% buying

145 buying97 selling
Last quarter: 145 funds were net buyers (57 opened a brand new position + 88 added to an existing one). Only 97 were sellers (53 trimmed + 44 sold completely). A clear majority buying is a strong confirmation signal.
📈

More new buyers each quarter (+20 vs last Q)

new funds entering per quarter
Funds opening a new SMMT position: 73 → 40 → 37 → 57. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
📌

Mixed — 35% long-term, 30% new

■ 35% conviction (2yr+) ■ 35% medium ■ 30% new
Of the 225 current holders: 79 (35%) held >2 years, 78 held 1–2 years, and 68 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.
📊

Peak discovery — momentum slowing

45 → 73 → 40 → 37 → 57 new funds/Q
New funds entering each quarter: 73 → 40 → 37 → 57. SMMT is well-known in the hedge fund world, but fresh entries are gradually declining. The explosive phase of institutional discovery is likely behind us.
🏛️

Deep conviction — 42% of holders stayed 2+ years

■ 42% veterans ■ 23% 1-2yr ■ 35% new
Of 240 current holders: 101 (42%) have held for over 2 years without selling. These are not momentum buyers — they have lived through drawdowns and stayed. A large veteran base acts as a stabilizing force during selloffs.
✅

Strong quality — 35% AUM from major funds

35% from top-100 AUM funds
41 of 225 holders rank in the top 100 by AUM, accounting for 35% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
3.4
out of 10
Low Exit Risk
Exit risk score 3.4/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — SMMT

In 2026 Q1, 145 hedge funds were net buyers of SMMT (57 opened a new position, 88 added to an existing one), while 97 reduced or exited (53 trimmed, 44 sold completely) — a 60% buyer ratio, indicating clear institutional accumulation. 35% of total institutional value in SMMT is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: +13 funds (more new holders than closures). Total institutional holders: 225.

Hedge Fund Ownership: SMMT

How many hedge funds hold SMMT — quarterly history vs. share price
Quarterly hedge fund ownership of SMMT vs. share price

Market Analysis: SMMT

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: SMMT

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Summit Therapeutics Inc (SMMT) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much SMMT has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 80d ago
SMMT
-26.8%
XLV
+2.1%

SMMT outperformed XLV by -28.9% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 35d ago
SMMT
-17.8%
XLV
+3.2%

Since the filing became public, SMMT outperformed XLV by -21.0% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

20 top-rated funds 1 high-conviction
Consensus
5.7
/ 10
breadth
×
Elite
1.4
/ 10
conviction
Hedge Fund Positioning: SMMT
225 + Investors

Track Smart Money conviction in SMMT. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 225 212 6.13%
13F Shares 123M 124M -1.02%
Total Value $2.17B $2.01B 8.2%
New Positions 57 37 +20
Increased Positions 83 76 +7
Closed Positions 44 60 -16
Reduced Positions 51 66 -15
Total Calls 11 7 57.14%
Total Puts 7 8 -12.5%
PUT/CALL Ratio 0.64 1.14 Bullish

Statistics: SMMT

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

225 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in SMMT. Verified SEC 13F-HR filings.

QUARTER:
Top 25 SMMT holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 APEIRON CAPITAL Ltd 23.21% 1,309,141 $24.8M
2 Superstring Capital Management LP 12.09% 892,873 $16.9M
3 Baker BROS. Advisors LP 3.96% 36,391,063 $690.0M
4 Sectoral Asset Management Inc 1.16% 69,615 $1.4M
5 Rock Springs Capital Management LP 0.79% 710,000 $13.5M
6 NEXTBio Capital Management LP 0.79% 89,717 $1.7M
7 QVT Financial LP 0.50% 360,524 $6.8M
8 Capstone Capital Management Ltd 0.44% 23,146 $439K
9 Griffin Asset Management, INC. 0.41% 191,872 $3.6M
10 Wealth Management Partners, LLC 0.35% 63,784 $1.2M
11 Fieldview Capital Management, LLC 0.27% 49,204 $933K
12 Polymer Capital Management (HK) LTD 0.22% 133,034 $2.5M
13 Arrowpoint Investment Partners (Singapore) Pte. Ltd. 0.20% 12,136 $230K
14 China Universal Asset Management Co., Ltd. 0.20% 137,596 $2.6M
15 E Fund Management Co., Ltd. 0.18% 311,825 $5.9M
16 VARCOV Co. 0.17% 23,509 $446K
17 Tema Etfs LLC 0.15% 119,531 $2.3M
18 PSP Research LLC 0.14% 10,223 $194K
19 Dark Forest Capital Management LP 0.14% 80,780 $1.5M
20 Havemeyer Place LP 0.14% 61,989 $1.2M
21 Axq Capital, LP 0.12% 47,268 $896K
22 Vance Wealth, LLC 0.11% 19,983 $379K
23 ADAR1 Capital Management, LLC 0.10% 91,869 $1.7M
24 Machina Capital S.A.S. 0.10% 26,199 $497K
25 Three Seasons Wealth, LLC 0.09% 12,869 $244K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Summit Therapeutics Inc (SMMT)

What does the Smart Money Trend signal show for SMMT?

Buying streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds added SMMT than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for SMMT?

More buyers than sellers — 60% buying: Last quarter: 145 funds were net buyers (57 opened a brand new position + 88 added to an existing one). Only 97 were sellers (53 trimmed + 44 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for SMMT holders?

Strong quality — 35% AUM from major funds: 41 of 225 holders rank in the top 100 by AUM, accounting for 35% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held SMMT?

Mixed — 35% long-term, 30% new: Of the 225 current holders: 79 (35%) held >2 years, 78 held 1–2 years, and 68 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

Is it too late to buy Summit Therapeutics Inc (SMMT) following the 2026 Q1 hedge fund 13F filings?

As of today, SMMT has moved -17.8% since the 2026 Q1 13F filing date (May 15, 2026), compared to +3.2% for the XLV sector ETF — an outperformance of -21.0%. Since the quarter end (March 31, 2026), SMMT has gained -26.8% vs +2.1% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →